Dynamics of Venture Capital Funding in the Bio-based Chemicals Industry

Following a drop in investment caused by the financial crisis, venture capital (VC) investment in bio-based materials and chemicals (BBMC) came back with a boom. VC investment rose steadily and reached a peak of $1.3 billion in 2011. However, the lackluster performances of both public and private BB...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Grab goes public in largest SPAC deal as merger talks with Gojek fail

News Commentary | April 08, 2021

Several rounds of rumors had suggested Grab and Gojek were nearing a merger. In a turn of events, Grab, Southeast Asia's largest startup, will likely raise more than $2 billion in funding by going public via the SPAC model through Altimeter. Financing from Ant Financial fell through along with the ... To read more, click here.

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B

News Commentary | July 08, 2021

L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription